LexDanaLexDanabeta
Inventor

Xin Lu

Inventor
Libertyville, IL, US

Overview

21→
Patents
2001–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms16%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
C12NMicroorganisms or enzymes7%
G06FElectric digital data processing7%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data7%
A61KPreparations for medical, dental or toiletry purposes6%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
C07KPeptides6%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology6%
C22BProduction and refining of metals3%
PatentTitleYear
11,039,145Image prediction method and apparatus202111,000,285Luminal grafts and methods of making and using the same202110,905,991Adsorbent breather for enclosure protection202110,829,833Biological processing of scrap metal, household waste and/or industrial waste for the isolation of heavy metals202010,501,822Biological ore processing for the isolation of heavy metals201910,047,403Diagnostic methods for determining prognosis of non-small cell lung cancer20189,880,171'iASPP phosphorylation and metastatic potential'20189,752,196'Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancer'20179,687,548'Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof'20179,297,045'Diagnostic methods for determining prognosis of non-small cell lung cancer'20169,291,625'Diagnostic methods for determining prognosis of non-small cell lung cancer'20169,002,653'Methods for assembling panels of cancer cell lines for use in testing the efficacy of one or more pharmaceutical compositions'20158,742,083'Panel of micrornas that silence the MCL-1 gene and sensitize cancer cells to ABT-263'20148,498,821'Genomic classification of malignant melanoma based on patterns of gene copy number alterations'20138,498,822'Genomic classification of colorectal cancer based on patterns of gene copy number alterations'20138,498,820'Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations'20138,318,441'Fibrinogen alpha and hemoglobin polypeptides as cancer markers'20127,745,571'Peptide inhibitors of IASPP'20107,723,019'Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof'20107,645,859'Tumour suppressor protein'20106,204,253'Factors which interact with oncoproteins'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2018Based in London, GB· patent location history
2012–2017Patents assigned to LU XIN (9)· patent assignee history
2013–2017Patents assigned to SEMIZAROV DIMITRI (8)· patent assignee history
2013–2016Patents assigned to LESNIEWSKI RICK R (6)· patent assignee history
2013–2016Patents assigned to ZHANG KE (6)· patent assignee history
2013–2015Patents assigned to ABBVIE INC (5)· patent assignee history
2013–2018Based in Libertyville, IL, US· patent location history
2019–2020Based in Essen, DE· patent location history
2021Based in Shenzhen, CN· patent location history
2021Based in San Diego, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LU XINself92012–2017
SEMIZAROV DIMITRI82013–2017
LESNIEWSKI RICK R62013–2016
ZHANG KE62013–2016
ABBVIE INC52013–2015
Locations
LocationPatentsSpan
Libertyville, Illinois, US92013–2018
London, GB42001–2018
Essen, DE22019–2020
Shenzhen, CN12021
San Diego, California, US12021